Actively Recruiting
Pacemaker Implantation Following Transcatheter Tricuspid Valve Replacement
Led by Deutsches Herzzentrum Muenchen · Updated on 2025-02-07
25
Participants Needed
1
Research Sites
56 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Transcatheter tricuspid valve replacement (TTVR) is associated with a high risk of third-degree atrioventricular block (AVB). However, the optimal pacemaker management following TTVR remains unclear. This study aims to identify an optimal therapeutic approach for pacemaker implantation in patients undergoing TTVR.
CONDITIONS
Official Title
Pacemaker Implantation Following Transcatheter Tricuspid Valve Replacement
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Transcatheter Tricuspid Valve Replacement
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Deutsches Herzzentrum München
München, Bavaria, Germany, 80796
Actively Recruiting
Research Team
C
Carsten Lennerz, PD Dr. med.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here